| Year |
Citation |
Score |
| 2023 |
Watzlawik JO, Fiesel FC, Fiorino G, Bustillos BA, Baninameh Z, Markham BN, Hou X, Hayes CS, Bredenberg JM, Kurchaba NW, Fričová D, Siuda J, Wszolek ZK, Noda S, Sato S, et al. Basal activity of PINK1 and PRKN in cell models and rodent brain. Autophagy. 1-12. PMID 38041584 DOI: 10.1080/15548627.2023.2286414 |
0.313 |
|
| 2023 |
Hou X, Heckman MG, Fiesel FC, Koga S, Soto-Beasley AI, Watzlawik JO, Zhao J, Valentino RR, Johnson PW, White LJ, Quicksall ZS, Reddy JS, Bras J, Guerreiro R, Zhao N, et al. Genome-wide association study identifies and variants as mitophagy modifiers in Lewy body disease. Medrxiv : the Preprint Server For Health Sciences. PMID 37905059 DOI: 10.1101/2023.10.16.23297100 |
0.39 |
|
| 2020 |
Watzlawik JO, Hou X, Truban D, Ramnarine C, Barodia SK, Gendron TF, Heckman MG, DeTure M, Siuda J, Wszolek ZK, Scherzer CR, Ross OA, Bu G, Dickson DW, Goldberg MS, et al. Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples. Autophagy. 1-16. PMID 33112198 DOI: 10.1080/15548627.2020.1834712 |
0.373 |
|
| 2020 |
Hou X, Watzlawik JO, Cook C, Liu CC, Kang SS, Lin WL, DeTure M, Heckman MG, Diehl NN, Al-Shaikh FSH, Walton RL, Ross OA, Melrose HL, Ertekin-Taner N, Bu G, et al. Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33090691 DOI: 10.1002/alz.12198 |
0.573 |
|
| 2018 |
Singh Angom R, Wang Y, Wang E, Pal K, Bhattacharya S, Watzlawik JO, Rosenberry TL, Das P, Mukhopadhyay D. VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802003R. PMID 30576228 DOI: 10.1096/Fj.201802003R |
0.369 |
|
| 2017 |
Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, Nguyen T, Malphrus KG, Lincoln S, Carrasquillo MM, Ho C, Chakrabarty P, Strickland S, Murray ME, Swarup V, et al. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29107053 DOI: 10.1016/J.Jalz.2017.09.012 |
0.474 |
|
| 2017 |
Allen M, Lincoln SJ, Corda M, Watzlawik JO, Carrasquillo MM, Reddy JS, Burgess JD, Nguyen T, Malphrus K, Petersen RC, Graff-Radford NR, Dickson DW, Ertekin-Taner N. ABCA7 loss-of-function variants, expression, and neurologic disease risk. Neurology. Genetics. 3: e126. PMID 28097223 DOI: 10.1212/Nxg.0000000000000126 |
0.532 |
|
| 2016 |
Watzlawik JO, Wootla B, Rodriguez M. Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression. Current Pharmaceutical Design. 22: 1049-59. PMID 26899126 DOI: 10.2174/1381612822666151215095940 |
0.34 |
|
| 2015 |
Watzlawik JO, Wootla B, Rodriguez M. Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression. Current Pharmaceutical Design. PMID 26667001 |
0.338 |
|
| 2015 |
Wootla B, Watzlawik JO, Warrington AE, Wittenberg NJ, Denic A, Xu X, Jordan LR, Papke LM, Zoecklein LJ, Pierce ML, Oh SH, Kantarci OH, Rodriguez M. Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases. Jama Neurology. PMID 26389734 DOI: 10.1001/Jamaneurol.2015.2188 |
0.302 |
|
| 2013 |
Wootla B, Watzlawik JO, Denic A, Rodriguez M. The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment. Expert Review of Clinical Immunology. 9: 535-49. PMID 23730884 DOI: 10.1586/Eci.13.37 |
0.336 |
|
| 2013 |
Skora L, Fonseca-Ornelas L, Hofele RV, Riedel D, Giller K, Watzlawik J, Schulz-Schaeffer WJ, Urlaub H, Becker S, Zweckstetter M. Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants. The Journal of Biological Chemistry. 288: 2994-3002. PMID 23209282 DOI: 10.1074/jbc.M112.423715 |
0.315 |
|
| Show low-probability matches. |